Back to BlackRock, Inc. BlackRock, Inc.

AKBAAKBA
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in AKEBIA THERAPEUTICS INC

BlackRock, Inc. holds 20M shares of AKBA (AKEBIA THERAPEUTICS INC), worth $22.8M as of 2026-Q2. The position was increased (+6.9% shares). AKBA represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$22.8M

Current Shares

20M

Total Value Change

+$2.7M

Total Shares Change

+4.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
20M
+6.9%
$22.8M0.0%$1.14
31
2026-Q1
Decreased
18.7M
-3.2%
$26M0.0%$1.22
0
2025-Q4
Increased
19.3M
+2.8%
$31.1M0.0%$1.59
30
2025-Q3
Increased
18.8M
+2.3%
$51.3M0.0%$2.71
30
2025-Q2
Increased
18.4M
+19.8%
$66.9M0.0%$3.65
35
2025-Q1
Increased
15.3M
+1.6%
$29.4M0.0%$1.91
29
2024-Q4
Decreased
15.1M
-0.7%
$28.7M0.0%$1.90
0
2024-Q3
First report
15.2M
-
$20.1M0.0%$1.32
0

Other major holders of AKBA: BNP PARIBAS FINANCIAL MARKETS, BAUPOST GROUP LLC/MA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used